Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2026 | From Nebraska to Orlando: NHO Revive Takes its Mission to SCRS Global Site Solutions Summit 2026 | NHO Revive, part of the Revival Site Network, is attending the Global Site Solutions Summit 2026, hosted by the Society for Clinical Research Sites NE, UNITED STATES, October 13, 2026 /EINPresswire.com/ -- NHO Revive, part of the Revival Si... |
| Sep 28, 2026 | NHO Revive Recognizes FDA Accelerated Approval of Camizestrant and Continued Research in Breast Cancer | NE, UNITED STATES, September 28, 2026 /EINPresswire.com/ -- The U.S. Food and Drug Administration (FDA) has granted accelerated approval to camizestrant (Etcamah) in combination with a CDK4/6 inhibitor for certain adults with hormone recept... |
| Jul 22, 2026 | NHO Revive Announces Expanded Access Protocol for Daraxonrasib | NHO Revive will offer pre-approval access to Daraxonrasib for eligible stage 4 pancreatic cancer patients through an Expanded Access Protocol. NEBRASKA, NE, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- NHO Revive is pleased to announc... |
| Jul 22, 2026 | NHO Revive Becomes Nebraska's Only Site for Groundbreaking Prostate Cancer Clinical Trial | NHO Revive becomes Nebraska's only site for a Johnson & Johnson Phase 3 trial testing a novel immune therapy for prostate cancer. NEBRASKA'S , NE, UNITED STATES, July 22, 2026 /EINPresswire.com/ -- The study, sponsored by John... |
Reviews 0
FAQ about NHO Revive
What has the press written about NHO Revive?
Parsers VC has collected 5 articles mentioning NHO Revive, among them “From Nebraska to Orlando: NHO Revive Takes its Mission to SCRS Global Site Solutions Summit 2026” (Oct 13, 2026) and “NHO Revive Recognizes FDA Accelerated Approval of Camizestrant and Continued Research in Breast Cancer” (Sep 28, 2026).
Is NHO Revive still active?
Yes, NHO Revive is active; its latest activity on Parsers VC dates from Oct 30, 2026.